author-photo

Naoki Takezako

Jichi Medical University

127

Papers

1646

Citations

Citation Trend

Filter By

Papers (83) Sort By

Journal Conference Others

Hypofibrinogenemia is associated with a high degree of risk in infectious diseases: a post-hoc analysis of post-marketing surveillance of patients with disseminated intravascular coagulation treated with thrombomodulin alfa.

2021 Thrombosis Journal
Show All
- Source
- Cite
- Save
Citations (1)
Importance of the Duration of TKI Treatment in Treatment-Free Remission of Chronic Phase Chronic Myeloid Leukemia: Results of D-Free Trial

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Balloon Kyphoplasty for Pathological Vertebral Fractures in Patients with Hematological Malignancies in Our Institution

2021 Internal Medicine
Show All
- Source
- Cite
- Save
Citations (0)
P-043: Comparison of MRD detection of autografts in multiple myeloma between novel high-sensitivity EuroFlow-NGF and NGS

2021 Clinical Lymphoma, Myeloma & Leukemia
Show All
- Source
- Cite
- Save
Citations (0)
Minimal Residual Disease in Autografts and Bone Marrow of Patients with Multiple Myeloma: 8-Color Multiparameter Flow Cytometry (EuroFlow-NGF) Vs. Next-Generation Sequencing

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Daratumumab plus lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: extended follow-up of POLLUX, a randomized, open-label, phase 3 study

2020 Leukemia
Show All
- Source
- Cite
- Save
Citations (71)
HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR.

2020 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Silent NK/T cell reactions to dasatinib during sustained DMR before cessation are associated with longer treatment‐free remission

2020 Cancer Science
Show All
- Source
- Cite
- Save
Citations (1)
Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial

2020 The Lancet Haematology
Show All
- Source
- Cite
- Save
Citations (28)
Pembrolizumab plus lenalidomide and dexamethasone in treatment-naive multiple myeloma (KEYNOTE-185): subgroup analysis in Japanese patients.

2020 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (1)